MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$113,041K
Net Income
$51,291K
Net Profit Margin
45.37%
EPS
$0.31
Unit: Thousand (K) dollars
Revenue Breakdown
Abbvie Plc-Collaborative Arrange...
Abbvie Plc-Collaborative Arrange...
Revenue from contract with custo...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenues
113,041
106,506
47,709
122,060
Research and development
22,421
21,940
21,863
22,468
Selling, general and administrative
11,313
12,033
19,293
21,908
Restructuring, net
-
-40
-252
2,200
Total costs and expenses
33,734
33,933
40,904
46,576
Income from operations
79,307
72,573
6,805
75,484
Interest expense and other financing costs
7,203
9,141
7,886
8,434
Interest and investment income
1,585
1,698
1,459
930
Other
42
42
77
40
Other income (expense), net
-5,576
-7,401
-6,350
-7,464
Income before income taxes
73,731
65,172
455
68,020
Income tax expense
22,440
24,399
2,731
27,940
Net income (gain)
51,291
40,773
-2,276
40,080
Basic EPS
0.31
0.25
-0.014
0.25
Diluted EPS
0.31
0.24
-0.017
0.23
Basic Average Shares
164,405,000
163,451,000
162,456,000
162,215,000
Diluted Average Shares
167,179,000
166,690,000
136,357,000
177,764,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Abbvie
Plc-Collaborative Arrangement...
$110,912K
(28.33%↑ Y/Y)
Abbvie
Plc-Collaborative Arrangement...
$1,113K
(23.12%↑ Y/Y)
Revenue from contract
with customer,...
$540K
Astellas Pharma
Inc-Collaborative Arrangement...
$397K
(-7.24%↓ Y/Y)
Collaborative Arrangement
Collaboration And License...
$79K
Total revenues
$113,041K
(32.62%↑ Y/Y)
Income from operations
$79,307K
(74.99%↑ Y/Y)
Total costs and
expenses
$33,734K
(-15.49%↓ Y/Y)
Income before income
taxes
$73,731K
(94.94%↑ Y/Y)
Other income
(expense), net
-$5,576K
(25.64%↑ Y/Y)
Interest and investment
income
$1,585K
(93.77%↑ Y/Y)
Other
$42K
(7.69%↑ Y/Y)
Research and development
$22,421K
(-4.07%↓ Y/Y)
Selling, general and
administrative
$11,313K
(-32.64%↓ Y/Y)
Net income (gain)
$51,291K
(117.34%↑ Y/Y)
Income tax expense
$22,440K
(57.77%↑ Y/Y)
Interest expense and
other financing costs
$7,203K
(-13.80%↓ Y/Y)
Buy us a coffee
IRONWOOD PHARMACEUTICALS INC (IRWD)
IRONWOOD PHARMACEUTICALS INC (IRWD)